Cancer Care

High-Veg, Low-Fat Diets Prevent Progression, Recurrence of Breast, Colon Cancer

By Janet Gulland | Contributing Writer - Vol. 7, No. 2. Summer, 2006

New data from the Women's Intervention Nutrition Study (WINS) and the Women's Healthy Eating and Lifestyle (WHEL) trial show clearly that low-fat, high-vegetable diets can reduce risk of breast cancer recurrence in high-risk women. The findings should prompt a re-thinking of the negative diet data from the Women's Health Initiative.

Scrap the War on Cancer, Start the War on Carcinogenesis

By Erik L. Goldman | Editor-in-Chief - Vol. 7, No. 1. Spring, 2006

The ongoing, lavishly-funded "war on cancer," is misguided because it is focused almost exclusively on genetics and end-stage high-tech treatments, while ignoring the biggest driving factor behind the cancer epidemic: environmental pollution. Dr. Mitchell Gaynor, a pioneer in integrative oncology, issues a call to action to the medical community and health conscious citizens.

Plant Medicines Offer Multiple Mechanisms Against Prostate Cancer

By Janet Gulland | Contributing Writer - Vol. 7, No. 1. Spring, 2006

Plant medicines can inhibit the growth of cancer through multiple biochemical mechanisms. A research team at the Columbia University Center for Holistic Urology is at the leading edge of science on herbal therapies for prostate cancer. The big stars are Zyflamend, a 10-herb anti-inflammatory combination, and Prostabel, a combo of Rauwolfia and Pau Pereira.

Fermented Wheat Germ Extract Improves Immunity, Survival in Cancer Patients

By Dale Chenoweth | Contributing Writer - Vol. 7, No. 1. Spring, 2006

A new medical food called Ave, and derived from fermented wheat germ, holds great promise as an adjunctive therapy for colorectal cancer, metastatic melanoma, childhood malignancies and other forms of cancer. Compounds in Ave starve cancer cells, enhance immune system activity, and reduce chemo-associated side effects.

AHCC and GCP: New Options for Urologic Cancers and Immune-Mediated Disorders

By Erik L. Goldman | Editor-in-Chief - Vol. 6, No. 2. Summer, 2005

Researchers from around the world gathered in New York to review current science on Activated Hexose Correlated Compound (AHCC) and Genistein Combined Polysaccharide (GCP), two compounds derived from Basidiomycetes mushrooms that are able to inhibit growth of prostate and bladder cancer cells.

Botanical Medicines Improve Immune Function, Prolong Survival in Cancer Patients

By Erik L. Goldman | Editor-in-Chief - Vol. 6, No. 1. Spring, 2005

Plant-based medicines including Bromelain (from pineapple), Chelidonium (a common Northeastern plant), and activated hexose correlated compound (derived from medicinal mushrooms) can strengthen immune function in cancer patients, leading to better treatment responses, longer survival and fewer recurrences. James Belanger, ND, a naturopathic oncologist, shares his approach.